Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-02-20, Stock:ABT, The news for the past five days is as follows:
2018-02-12: NEWS1: How Bard Acquisition Could Benefit BD.NEWS2: What BD Expects for 2018.NEWS3: How BD Stock Has Performed in the Last Year.NEWS4: Abbott's FreeStyle LibreLink App Now Available in Europe.NEWS5: Abbott's FreeStyle LibreLink App Now Available in Europe.NEWS6: How Did BDX’s LifeSciences Business Perform in Fiscal 1Q18?.NEWS7: Abbott&apos;s FreeStyle LibreLink App Now Available in Europe.NEWS8: BDX’s Fiscal 1Q18 Earnings Results Beat Analysts’ Estimates.
2018-02-13: NEWS1: What Analysts Recommend for Medtronic ahead of 1Q18 Earnings.NEWS2: Will Medtronic See Lower Sales Again in 3Q18?.NEWS3: What Wall Street Thinks about BD after 1Q18 Earnings Release.NEWS4: Investor Update: BD’s Recent Dividend Announcement.
2018-02-14: NEWS1: Heartbreak And Desire: 11 Of Our Favorite Wall Street Love Stories.NEWS2: Analysts Anticipate XRLV To Hit $37.NEWS3: Analysts Anticipate XRLV To Hit $37.
2018-02-15: NEWS1: A Snapshot Of Abbott Labs' Business.NEWS2: A Snapshot Of Abbott Labs' Business.NEWS3: Noteworthy ETF Outflows: IWB, MDT, UNP, ABT.NEWS4: Noteworthy ETF Outflows: IWB, MDT, UNP, ABT.NEWS5: Today’s Research Reports on Trending Tickers: Gilead Sciences and Abbott Laboratories.NEWS6: 7 ‘Strong Buy’ Stocks That Look Cheap Right Now.NEWS7: 7 ‘Strong Buy’ Stocks That Look Cheap Right Now.
2018-02-16: NEWS1: Abbott Laboratories (ABT) Files 10-K for the Fiscal Year Ended on December 31, 2017.NEWS2: Abbott Laboratories (NYSE:ABT): Does The -66.57% Earnings Decline Make It An Underperformer?.NEWS3: Abbott Laboratories Jumps After Boosting Quarterly Dividend.NEWS4: Boston Scientific’s 4Q17 Sales Exceeded Analysts’ Estimates.NEWS5: Abbott Laboratories Jumps After Boosting Quarterly Dividend.NEWS6: Abbott Laboratories Jumps After Boosting Quarterly Dividend.NEWS7: BSX’s Anticipated Lotus Valve Relaunch: Not before 2019.NEWS8: FDA Grants Agios' (AGIO) Leukemia Candidate Priority Review.NEWS9: FDA Grants Agios' (AGIO) Leukemia Candidate Priority Review.NEWS10: BSX Stock Regains Momentum after Its Recent Bearish Trend.NEWS11: Cardiovascular Systems Portfolio Solid, Competition Rife.NEWS12: Cardiovascular Systems Portfolio Solid, Competition Rife.NEWS13: Abbott Declares 377th Consecutive Quarterly Dividend.NEWS14: FDA Grants Agios&apos; (AGIO) Leukemia Candidate Priority Review.NEWS15: Did AbbVie, Inc. Just Become the Most Shareholder-Friendly Stock in America?.NEWS16: Did AbbVie, Inc. Just Become the Most Shareholder-Friendly Stock in America?.

Answer: Decrease